SCHEMBL26418778

SCHEMBL26418778

CO/C=C(\Oc1cc(Cc2ccccc2)ccc1C)C(=O)OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MPO P05164 1/20 0.39
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
ATM Q13315 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TACR1 P25103 1/20 0.37
TACR3 P29371 1/20 0.37
LMNA P02545 2/20 0.36
HNF4A P41235 1/20 0.36
SLC22A12 Q96S37 1/20 0.36
OPRK1 P41145 2/20 0.36
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRB2 P47870 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26418764 0.85 FFAR1 (0.44) MEN1MAPTKMT2ATDP1LMNA
SCHEMBL23712445 0.85 CYP4F2 (0.40) MEN1MAPTKMT2AATMTDP1
SCHEMBL26418742 0.84 PKM (0.39) MEN1MAPTKMT2AATMTDP1
SCHEMBL26416220 0.82 NPC1 (0.39) MEN1KMT2ASMN1; SMN2ALDH1A1POLB
SCHEMBL23712641 0.82 LTA4H (0.40) MPOMEN1MAPTKMT2AATM
SCHEMBL8020542 0.82 ALDH1A1 (0.35) MEN1MAPTKMT2ATDP1L3MBTL1
SCHEMBL31423338 0.81 MEN1 (0.39) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL31387874 0.81 MEN1 (0.39) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL30784639 0.81 MEN1 (0.39) MEN1MAPTKMT2AALDH1A1POLB
SCHEMBL7783807 0.81 MEN1 (0.39) MEN1MAPTKMT2AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127143-A1 METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127143-A1 METHOD FOR CONTROLLING PHAKOPSORA PACHYRHIZI HAVING RESISTANCE AGAINST QoI FUNGICIDE CYC1, COX5B, SQOR MPO 3362/4885MEN1 2799/4885MAPT 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.